A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling

被引：0
|
作者：
H. van den Bongard
R. Mathôt
O. van Tellingen
J. Schellens
J. Beijnen
机构：
[1] Department of Pharmacy and Pharmacology,
[2] Slotervaart Hospital/The Netherlands Cancer Institute,undefined
[3] Louwesweg 6,undefined
[4] 1066 EC Amsterdam,undefined
[5] The Netherlands,undefined
[6] Department of Clinical Chemistry Laboratory,undefined
[7] Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute,undefined
[8] Amsterdam,undefined
[9] The Netherlands,undefined
[10] Department of Medical Oncology,undefined
[11] Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute,undefined
[12] Amsterdam,undefined
[13] The Netherlands,undefined
[14] Division of Drug Toxicology,undefined
[15] Department of Biomedical Analysis,undefined
[16] Faculty of Pharmacy,undefined
[17] Utrecht University,undefined
[18] Utrecht,undefined
[19] The Netherlands,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2002年 / 50卷
关键词：
Cremophor EL Population pharmacokinetic model Validation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Abstract
引用
收藏
页码：16 / 24
页数：8
相关论文
共 50 条
  • [1] A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling
    van den Bongard, HJGD
    Mathôt, RAA
    van Tellingen, O
    Schellens, JHM
    Beijnen, JH
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (01) : 16 - 24
  • [2] A population pharmacokinetic model for Cremophor EL using nonlinear mixed-effect modeling:: model building and validation
    Van Den Bongard, HJGD
    Mathôt, RAA
    Van Tellingen, O
    Schellens, JHM
    Beijnen, JH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (05) : 552P - 553P
  • [3] Carbamazepine population pharmacokinetics in children: Mixed-effect models
    Iribarnegaray, MFD
    Buelga, DS
    Sanchez, MJG
    Otero, MJ
    Falcao, AC
    [J]. THERAPEUTIC DRUG MONITORING, 1997, 19 (02) : 132 - 139
  • [4] Population pharmacokinetics of orally administered paclitaxel formulated in Cremophor EL
    de Jonge, ME
    Huitema, AD
    Schellens, JH
    Rodenhuis, S
    Beijnen, JH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (03) : 325 - 334
  • [5] Integrating dynamic mixed-effect modelling and penalized regression to explore genetic association with pharmacokinetics
    Bertrand, Julie
    De Iorio, Maria
    Balding, David J.
    [J]. PHARMACOGENETICS AND GENOMICS, 2015, 25 (05): : 231 - 238
  • [6] Population pharmacokinetics of topiramate in adult patients with epilepsy using nonlinear mixed effects modelling
    Jovanovic, Marija
    Sokic, Dragoslav
    Grabnar, Iztok
    Vovk, Tomaz
    Prostran, Milica
    Vucicevic, Katarina
    Miljkovic, Branislava
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 50 (3-4) : 282 - 289
  • [7] Reliability analysis using the least squares method in nonlinear mixed-effect degradation models
    Wu, SJ
    Shao, J
    [J]. STATISTICA SINICA, 1999, 9 (03) : 855 - 877
  • [8] Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL
    Sparreboom, A
    vanTellingen, O
    Nooijen, WJ
    Beijnen, JH
    [J]. CANCER RESEARCH, 1996, 56 (09) : 2112 - 2115
  • [9] Population pharmacokinetics of cyclosporin in lung transplant patients: mixed-effect modeling and development of a Bayesian estimator using NONMEM
    Saint-Marcoux, F
    Rousseau, A
    Debord, J
    Estenne, M
    Bernard, N
    Marquet, P
    [J]. THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 504 - 504
  • [10] Effect of the paclitaxel vehicle, Cremophor EL, on the pharmacokinetics of doxorubicin and doxorubicinol in mice
    Webster, LK
    Cosson, EJ
    Stokes, KH
    Millward, MJ
    [J]. BRITISH JOURNAL OF CANCER, 1996, 73 (04) : 522 - 524
12345